Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Critical Roles of IL-33/ST2 Pathway in Neurological Disorders.

Abd Rachman Isnadi MF, Chin VK, Abd Majid R, Lee TY, Atmadini Abdullah M, Bello Omenesa R, Osamah Ibraheem Z, Basir R.

Mediators Inflamm. 2018 Feb 4;2018:5346413. doi: 10.1155/2018/5346413. eCollection 2018. Review.

2.

Immune and Imaging Correlates of Mild Cognitive Impairment Conversion to Alzheimer's Disease.

La Rosa F, Saresella M, Baglio F, Piancone F, Marventano I, Calabrese E, Nemni R, Ripamonti E, Cabinio M, Clerici M.

Sci Rep. 2017 Dec 1;7(1):16760. doi: 10.1038/s41598-017-16754-y.

3.

Association of interleukin-33 gene polymorphisms with susceptibility to late onset Alzheimer's disease: a meta-analysis.

Zhong X, Liu MY, He M, Du K, Wei MJ.

Neuropsychiatr Dis Treat. 2017 Aug 30;13:2275-2284. doi: 10.2147/NDT.S138073. eCollection 2017.

4.

Interleukin33 deficiency causes tau abnormality and neurodegeneration with Alzheimer-like symptoms in aged mice.

Carlock C, Wu J, Shim J, Moreno-Gonzalez I, Pitcher MR, Hicks J, Suzuki A, Iwata J, Quevedo J, Lou Y.

Transl Psychiatry. 2017 Jul 4;7(7):e1164. doi: 10.1038/tp.2017.142. Erratum in: Transl Psychiatry. 2017 Aug 1;7(8):e1191.

5.

Role of IL-33 and ST2 signalling pathway in multiple sclerosis: expression by oligodendrocytes and inhibition of myelination in central nervous system.

Allan D, Fairlie-Clarke KJ, Elliott C, Schuh C, Barnett SC, Lassmann H, Linnington C, Jiang HR.

Acta Neuropathol Commun. 2016 Jul 26;4(1):75. doi: 10.1186/s40478-016-0344-1.

6.

IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline.

Fu AK, Hung KW, Yuen MY, Zhou X, Mak DS, Chan IC, Cheung TH, Zhang B, Fu WY, Liew FY, Ip NY.

Proc Natl Acad Sci U S A. 2016 May 10;113(19):E2705-13. doi: 10.1073/pnas.1604032113. Epub 2016 Apr 18.

7.
8.

Association of IL-1, IL-18, and IL-33 gene polymorphisms with late-onset Alzheimer׳s disease in a Hunan Han Chinese population.

Tian M, Deng YY, Hou DR, Li W, Feng XL, Yu ZL.

Brain Res. 2015 Jan 30;1596:136-45. doi: 10.1016/j.brainres.2014.11.019. Epub 2014 Nov 20.

PMID:
25446437
9.

Analysis of Differentially Expressed Genes Associated With Alzheimer's Disease Based on Bioinformatics Methods.

Feng B, Hu P, Chen J, Liu Q, Li X, Du Y.

Am J Alzheimers Dis Other Demen. 2015 Dec;30(8):746-51. doi: 10.1177/1533317514537548. Epub 2014 Jun 24.

PMID:
24965283
10.

Alzheimer's disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brain.

Xiong Z, Thangavel R, Kempuraj D, Yang E, Zaheer S, Zaheer A.

J Alzheimers Dis. 2014;40(2):297-308. doi: 10.3233/JAD-132081.

11.

Glia maturation factor induces interleukin-33 release from astrocytes: implications for neurodegenerative diseases.

Kempuraj D, Khan MM, Thangavel R, Xiong Z, Yang E, Zaheer A.

J Neuroimmune Pharmacol. 2013 Jun;8(3):643-50. doi: 10.1007/s11481-013-9439-7. Epub 2013 Feb 10.

12.

Molecular basis of applied biological therapeutics.

Andersson U, Tracey KJ.

J Intern Med. 2011 Jan;269(1):2-7. Review. No abstract available.

13.

Implication of IL-33 gene polymorphism in Chinese patients with Alzheimer's disease.

Yu JT, Song JH, Wang ND, Wu ZC, Zhang Q, Zhang N, Zhang W, Xuan SY, Tan L.

Neurobiol Aging. 2012 May;33(5):1014.e11-4. doi: 10.1016/j.neurobiolaging.2010.07.003. Epub 2010 Aug 13.

PMID:
20708824
14.

Over-expression of IL-33 leads to spontaneous pulmonary inflammation in mIL-33 transgenic mice.

Zhiguang X, Wei C, Steven R, Wei D, Wei Z, Rong M, Zhanguo L, Lianfeng Z.

Immunol Lett. 2010 Jul 8;131(2):159-65. doi: 10.1016/j.imlet.2010.04.005. Epub 2010 Apr 20.

PMID:
20412815
15.

Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease.

Chapuis J, Hot D, Hansmannel F, Kerdraon O, Ferreira S, Hubans C, Maurage CA, Huot L, Bensemain F, Laumet G, Ayral AM, Fievet N, Hauw JJ, DeKosky ST, Lemoine Y, Iwatsubo T, Wavrant-Devrièze F, Dartigues JF, Tzourio C, Buée L, Pasquier F, Berr C, Mann D, Lendon C, Alpérovitch A, Kamboh MI, Amouyel P, Lambert JC.

Mol Psychiatry. 2009 Nov;14(11):1004-16. doi: 10.1038/mp.2009.10. Epub 2009 Feb 10.

Supplemental Content

Loading ...
Support Center